School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Mikrochim Acta. 2022 Mar 1;189(3):125. doi: 10.1007/s00604-022-05213-9.
A novel electrochemical sensor is reported for the detection of the antiviral drug favipiravir based on the core-shell nanocomposite of flower-like molybdenum disulfide (MoS) nanospheres and molecularly imprinted polymers (MIPs). The MoS@MIP core-shell nanocomposite was prepared via the electrodeposition of a MIP layer on the MoS modified electrode, using o-phenylenediamine as the monomer and favipiravir as the template. The selective binding of target favipiravir at the MoS@MIP core-shell nanocomposite produced a redox signal in a concentration dependent manner, which was used for the quantitative analysis. The preparation process of the MoS@MIP core-shell nanocomposite was optimized. Under the optimal conditions, the sensor exhibited a wide linear response range of 0.01 ~ 100 nM (1.5710 ~ 1.5710 μg mL) and a low detection limit of 0.002 nM (3.14*10 μg mL). Application of the sensor was demonstrated by detecting favipiravir in a minimum amount of 10 μL biological samples (urine and plasma). Satisfied results in the recovery tests indicated a high potential of favipiravir monitoring in infectious COVID-19 samples.
一种基于花状二硫化钼 (MoS) 纳米球和分子印迹聚合物 (MIP) 的核壳纳米复合材料的新型电化学传感器被报道用于检测抗病毒药物法匹拉韦。通过在 MoS 修饰电极上电沉积 MIP 层,使用邻苯二胺作为单体和法匹拉韦作为模板,制备了 MoS@MIP 核壳纳米复合材料。目标法匹拉韦在 MoS@MIP 核壳纳米复合材料上的选择性结合以浓度依赖的方式产生了氧化还原信号,用于定量分析。优化了 MoS@MIP 核壳纳米复合材料的制备工艺。在最佳条件下,传感器表现出宽线性响应范围为 0.01100 nM(1.57*101.5710 μg mL)和低检测限为 0.002 nM(3.1410 μg mL)。通过在最小量为 10 μL 的生物样本(尿液和血浆)中检测法匹拉韦,证明了传感器的应用。在回收率测试中得到了满意的结果,表明该传感器在监测传染性 COVID-19 样本中的法匹拉韦具有很高的潜力。